Author: CSN
Wyoming Opts Out Of Federal Medical Cannabis Rescheduling
Wyoming Attorney General Keith Kautz has determined that the medical cannabis rescheduling won’t apply to his state.
Investors Are Starting To Ask Cannabis Companies Different Questions
As institutional capital enters cannabis, workforce risk is reshaping valuations. Learn why HR compliance and culture now drive M&A, diligence,…
MSOS: Adult-Use Rescheduling The Next Catalyst For Cannabis Stocks
The AdvisorShares Pure US Cannabis ETF is rated a buy, driven by real regulatory progress and potential further catalysts. Click…
Maryland loosens rule for investing in some cannabis businesses
Maryland cannabis leaders hope that looser ownership rules could attract more outside investment, but some experts say a larger issue…
Why Is Trulieve Cannabis (NYSE:TRLV) Watching NYSE Composite?
Explore Trulieve Cannabis (NYSE:TRLV), operating across regulated cannabis markets, with insights into business operations, Florida presence, and the company’s role…
Beverage company bets on cannabis-based epilepsy drug, secures $1 million investment
The Fort Lauderdale company is expanding beyond beverages with a deal that gives it global rights to an epilepsy therapy…
Is Canopy Growth stock finally worth buying after losing 99% of its value?
A lower stock price doesn’t eliminate investment risk.
D.C. Circuit challenge and DEA hearing put federal cannabis rescheduling to the test
Alexander Malyshev and Sarah Ganley of Carter Ledyard & Milburn LLP examine the dual developments over the federal government’s cannabis…
Tilray’s stock is down over 50% this year. Has it become a bargain buy?
The cannabis stock recently hit a new 52-week low.
2 Kansas Democrats running for governor embrace recreational marijuana
Cindy Holscher and Ethan Corson on Tuesday both called for the legalization of recreational marijuana in Kansas, separating themselves from…
Recent Comments